[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-insider-selling-catalyst-pharm3301938045-f53b-7097-8862-f60315010dd6":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":23,"enrichStatus":19,"triageKind":18,"triageImportance":18,"expandEligible":18,"summarizeEligible":18,"eventEligible":18,"eventType":18,"eventAction":18},"insider-selling-catalyst-pharm3301938045-f53b-7097-8862-f60315010dd6","1733022924000","Insider Selling: Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Director Sells 17,500 Shares of Stock","Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Get Free Report) Director Molly Harper sold 17,500 shares of the business's stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $22.00, for a total transaction of $385,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.","https://www.marketbeat.com/instant-alerts/insider-selling-catalyst-pharmaceuticals-inc-nasdaqcprx-director-sells-17500-shares-of-stock-2024-11-29/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"-\"]","[{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","1"]